<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alkaline phosphatase (ALP) activity was evaluated histochemically and cytochemically in concert with immunologic technics in 60 cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and lymphocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Surface membranes of neoplastic cells were positive for ALP only in certain B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>: 3 of 6 lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of intermediate differentiation, 4 of 13 nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 1 of 7 Burkett's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, well-differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and diffuse "histiocytic" <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, were ALP-negative </plain></SENT>
<SENT sid="3" pm="."><plain>The neoplastic cells of <z:e sem="disease" ids="C0036920" disease_type="Neoplastic Process" abbrv="">Sezary syndrome</z:e> and lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were also consistently negative for ALP </plain></SENT>
<SENT sid="4" pm="."><plain>In control lymph nodes ALP-positive lymphocytes were present only in primary follicles and in mantle zones of secondary follicles </plain></SENT>
<SENT sid="5" pm="."><plain>ALP-positive <z:hpo ids='HP_0002665'>lymphomas</z:hpo> appear to be neoplastic counterparts of these <z:mpath ids='MPATH_458'>normal</z:mpath> lymphocytes, not only cytochemically, but also with respect to their morphologic and immunologic characteristics </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, histochemical inhibition tests suggested that the ALP activity demonstrated may reflect a newly recognized, unique isoenzyme </plain></SENT>
</text></document>